FDA Inspection
Cetylite Industries, Inc.Cetylite Industries, Inc. – FDA Inspection, May 29, 2018
Record Details
This FDA Inspection record concerns Cetylite Industries, Inc., with an inspection on May 29, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · db131590-6fb2-40bb-8b62-17f24d6b7251
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1053508
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
8- 21 CFR 211.137(a)Expiration date lacking
- 21 CFR 211.165(f)Failing drug products not rejected
- 21 CFR 211.80(d)Status of Each Lot Identified
- 21 CFR 310.305(c)(1)(i)Late submission
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.25(c)Inadequate number of personnel
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 310.305(a)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Cetylite Industries, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| April 7, 2025 | NAI | New Jersey District Office | Postmarket Assurance: Medical Devices |
| December 9, 2024 | VAI | New Jersey District Office | Drug Quality Assurance |
| March 2, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 24, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 19, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cetylite Industries, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.